Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

29 June 2012

Repeated graft loss after orthotopic liver transplantation: A case report

Oskar KornasiewiczACDEF, Karol ZbrońskiABCE, Michał GrątABC, Krzysztof ZieniewiczD, Marek KawczykAG

DOI: 10.12659/AOT.883232

Ann Transplant 2012; 17(2): 131-134

Abstract

Background: Multiple orthotopic liver transplantations (OLTx), although relatively uncommon, are the only known therapy for repeated graft failure. Moreover, re-transplantation (re-OLTx) of more than 2 grafts is sparsely reported thus far.
Case Report: We describe here 2 cases of patients who fulfilled the criteria for undergoing more than 2 OLTx. Each patient received 3 grafts in total. The primary early indication for the first re-OLTx in both cases was hepatic artery thrombosis (HAT). Prior to the second re-OLTx, both patients were in poor general condition. In 1 case, the second graft failed due to the recurrence of primary sclerosing cholangitis; the patient was re-transplanted electively 69 months after the primary re-OLTx. In the other case, the patient required a non-elective second re-OLTx within 1 month after the first re-OLTx due to primary graft failure. In both patients, the second and the third re-OLTs were performed using a veno-venous bypass with hepaticojejunostomy on an already existing Roux-en-Y loop. While 1 patient died postoperatively due to multi-organ failure, the other is alive with good synthetic liver function at 60 months after the last transplantation. The overall mortality rate of this procedure was thus 50%.
Conclusions: Although repeated OLT of more than 2 grafts is technically feasible and in selected patients can be a life-saving procedure, it is rarely performed. In our limited experience, it is burdened with relatively high mortality and morbidity, unspecified indications regarding patient selection, and competition between patients awaiting liver transplantation.

Keywords: hepatic artery thrombosis, re-transplantation, primary nonfunction

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358